We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
CLEU | China Liberal Education Holdings Ltd | 3.1505 | 1.13 | 55.97% | 18,308,406 |
HUDA | Hudson Acquisition I Corporation | 16.6999 | 5.75 | 52.51% | 634,303 |
VERO | Venus Concept Inc | 0.893101 | 0.3064 | 52.22% | 69,484,206 |
HRYU | Hanryu Holdings Inc | 0.5047 | 0.1456 | 40.55% | 2,831,250 |
HUDAU | Hudson Acquisition I Corporation | 15.77 | 3.66 | 30.22% | 3,765 |
AONC | American Oncology Network Inc | 2.20 | 0.50 | 29.41% | 5,247,290 |
XTKG | X3 Holdings Company Ltd | 0.76 | 0.17 | 28.81% | 849,842 |
LFLY | Leafly Holdings Inc | 2.5601 | 0.5401 | 26.74% | 36,837,302 |
CMLS | Cumulus Media Inc | 2.45 | 0.50 | 25.64% | 155,140 |
SISI | Shineco Inc | 2.77 | 0.49 | 21.49% | 281,694 |
VIRC | Virco Manufacturing Company | 13.15 | 2.29 | 21.09% | 523,566 |
SHANGHAI, June 7, 2024 /PRNewswire/ -- Nisun International Enterprise Development Group Co., Ltd ("Nisun International" or the "Company") (Nasdaq: NISN), a technology and industry driven integrated supply chain solutions provider, today announced that it has achieved a significant breakthrough in its egg business following the Company stepping into the egg industry.
Transaction ensures Nestlé Health Science will continue to commercialize the product BRIDGEWATER, N.J., June 6, 2024 /PRNewswire/ -- Seres Therapeutics, Inc. (Nasdaq: MCRB), announced today that it has agreed to a non-binding memorandum of understanding with Nestlé Health Science in which Nestlé Health Science will acquire certain tangible and intangible assets associated with VOWST (fecal microbiota spores, live-brpk) capsules. This transaction, when completed, supersedes any prior agreements between Nestlé and Seres concerning VOWST. Nestlé Health Science has been the lead commercialization party for the product since its launch in June 2023 in the United States. This transaction will allow Nestlé Health Science ...
The April 1st partial legalization of cannabis in Germany, has potentially paved the way for tremendous category growth. With a population of over 83 million, Germany has more than double the population of California, which had a cannabis industry of about $5 billion in 2023.[1] Until the social clubs are up and running, the only legal way to buy cannabis in Germany is with a prescription, driving significant growth in the Medical Market.
JERUSALEM, June 7, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) (the "Company"), a biotechnology company focused on developing inflammation and immunology (I&I) biological products and on providing CDMO services through its Scinai Bioservices business unit, today announced that on June 5, 2024, it received formal notification from the Listing Qualification Department (the "Staff") of the Nasdaq Stock Market ("Nasdaq") that the Company has regained compliance with the minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the "Rule").
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 69,292.29 | -40.11 | -0.06% | 1.36T | 5,089,995,367 |
ETH | Ethereum | 3,677.88 | 1.08 | 0.03% | 441.81B | 2,673,202,988 |
BNB | Binance Coin | 683.59 | 0.00 | 0.00% | 107.94B | 523,395,468 |
USDT | Tether USD | 0.99956 | 0.00 | 0.00% | 97.8B | 274,992,819 |
SOL | Solana | 162.18 | -0.280 | -0.17% | 71.62B | 1,121,122,189 |
STETH | stETH | 3,675.78 | 0.44982 | 0.01% | 36.04B | 13,461,977 |
USDC | USD Coin | 0.9999 | 0.00 | 0.00% | 28.07B | 1,001,764,065 |
XRP | Ripple | 0.4973 | -0.0016 | -0.32% | 27.22B | 449,534,168 |
TONCOIN | Wrapped TON Coin | 7.23 | 0.000885 | 0.01% | 25.09B | 227,431,331 |
DOGE | Dogecoin | 0.14825 | 0.00 | 0.00% | 21.23B | 433,788,388 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions